Ledger.Open graph →
SEC Form D · filed April 26, 2017

Respira Therapeutics, Inc

Offering
$9.4M
Sold
$9.1M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
ALBUQUERQUE, NM
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (10)

David M. Blivin · Albuquerque, NMDirectorMatthew P. Franklin · Albuquerque, NMExecAndrew M. Clark · Albuquerque, NMDirectorRobert M. Curtis · Albuquerque, NMExec · DirectorBrian P. Birk · Albuquerque, NMDirectorDavid M. Blivin · Albuquerque, NMDirectorMatthew P. Franklin · Albuquerque, NMExecAndrew M. Clark · Albuquerque, NMDirectorRobert M. Curtis · Albuquerque, NMExec · DirectorBrian P. Birk · Albuquerque, NMDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗